Search

Your search keyword '"Moisés Rodríguez-Mañero"' showing total 273 results

Search Constraints

Start Over You searched for: Author "Moisés Rodríguez-Mañero" Remove constraint Author: "Moisés Rodríguez-Mañero"
273 results on '"Moisés Rodríguez-Mañero"'

Search Results

1. Effect of age on clinical impact and mid-term denervation in patients undergoing cardioneuroablation

2. Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

Catalog

Books, media, physical & digital resources

3. Atrial fibrillation ablation in patients with arrhythmia‐induced cardiomyopathy: a prospective multicentre study

4. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

5. Influence of body mass index on recurrence of atrial fibrillation after electrical cardioversion.

6. Long‐term cardiac reverse remodeling after cardiac resynchronization therapy

7. Searching for genetic modulators of the phenotypic heterogeneity in Brugada syndrome

8. Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation

9. Neuromodulatory Approaches for Atrial Fibrillation Ablation

10. Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature

11. Coronary vein defibrillator coil placement in patients with high defibrillation thresholds

12. Prevalence and outcomes of atrial fibrillation in a European healthcare area gained through the processing of a health information technology system

13. Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy

14. Cardiac resynchronization therapy outcomes in patients under nonoptimal medical therapy

15. Prognostic value of nutrition status in the response of cardiac resynchronization therapy

16. NS5806 Induces Electromechanically Discordant Alternans and Arrhythmogenic Voltage-Calcium Dynamics in the Isolated Intact Rabbit Heart

17. Omentin protects H9c2 cells against docetaxel cardiotoxicity.

18. Initial experience and treatment of atrial fibrillation using a novel irrigated multielectrode catheter: Results from a prospective two-center study

19. La hiponatremia como marcador de riesgo en pacientes sometidos a implante de desfibrilador en prevención primaria

20. Simultaneous wide and narrow QRS complex tachycardia: what is the mechanism?

21. Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years

22. Permanent junctional reciprocating tachycardia in a patient with an atypically located accessory pathway in the left lateral mitral annulus

24. Combination of Hansen Robotic system with cryocatheter in a challenging parahisian accessory pathway ablation

25. A novel electrocardiographic index for the diagnosis of diastolic dysfunction.

27. Effects of guideline-directed medical therapy in patients with left bundle branch block-induced cardiomyopathy

28. Remnant cholesterol in patients admitted for acute coronary syndromes

32. Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril–Valsartan in Clinical Trials

33. Validación de escalas multiparamétricas de predicción de riesgo de muerte súbita en pacientes con síndrome de Brugada y estudio electrofisiológico

34. Clinical Profiling and Biomarkers for Post-Operative Atrial Fibrillation Prediction in Patients Undergoing Cardiac Surgery

35. Impact on Accessibility to Care and Outcomes of a Clinician-to-Clinician Electronic Consultation Program in Heart Failure Patients with Previous Hospital Admissions: Implications for Heart Failure Care

37. Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

38. Gender differences on healthcare accessibility and outcomes of a electronic inter-clinician consultation program at the cardiology department in a Galician Health Area

40. Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study

42. Effect of <scp>PCSK9</scp> inhibitors on remnant cholesterol and lipid residual risk: The <scp>LIPID‐REAL</scp> registry

43. New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction

44. Insuficiencia cardiaca de novo tras un síndrome coronario agudo en pacientes sin insuficiencia cardiaca ni disfunción ventricular izquierda

45. Selección de lo mejor del año 2020 en arritmias cardiacas

46. Mortality associated with cardiovascular disease in patients with COVID-19

47. Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin

48. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

49. Estimation of the major cardiovascular events prevention with Inclisiran

50. Radiofrequency ablation of an atypical left accessory pathway from the left coronary cusp